Literature DB >> 4296784

[Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].

R Maral, G Bourat, R Ducrot, J Fournel, P Ganter, L Julou, F Koenig, J Myon, S Pascal, J Pasquet, P Populaire, Y de Ratuld, G H Werner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4296784

Source DB:  PubMed          Journal:  Pathol Biol


× No keyword cloud information.
  6 in total

1.  Daunorubicin and the heart.

Authors: 
Journal:  Br Med J       Date:  1974-11-23

2.  Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts.

Authors:  E Bachmann; E Weber; G Zbinden
Journal:  Agents Actions       Date:  1975-10

3.  Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.

Authors:  H M Olson; D M Young; D J Prieur; A F LeRoy; R L Reagan
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

4.  Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.

Authors:  Gustav Holmgren; Jane Synnergren; Yalda Bogestål; Caroline Améen; Karolina Åkesson; Sandra Holmgren; Anders Lindahl; Peter Sartipy
Journal:  Toxicology       Date:  2014-12-18       Impact factor: 4.221

5.  An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy.

Authors:  Jesús Talavera; Alejandro Giraldo; María Josefa Fernández-Del-Palacio; Obdulio García-Nicolás; Juan Seva; Gavin Brooks; Jose M Moraleda
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

Review 6.  Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician.

Authors:  Ekaterina Yu Podyacheva; Ekaterina A Kushnareva; Andrei A Karpov; Yana G Toropova
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.